)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Genfit
Genfit (GNFT) investor relations material
Genfit H.C. Wainwright 28th Annual Global Investment Conference presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H.C. Wainwright 28th Annual Global Investment Conference presentation summary15 Sep, 2026
Strategic partnerships and financial position
Maintains strong cash position of €136.1M as of 1Q26, with cash runway projected beyond 2028 and no debt overhang.
Partnership with Ipsen for elafibranor in PBC has yielded €105.5M in milestones and €34M in royalties to date, with potential for up to €360M in milestones and double-digit royalties.
Royalty financing agreement with HCRX provided €160M, with milestones excluded from the deal.
Commercial and clinical progress of elafibranor (Iqirvo)
Iqirvo launched in 2024 for PBC, achieving strong sales growth and upgraded peak sales guidance to €1bn.
ELSPIRE Phase IIIb study showed 85% ALP normalization in PBC patients, significantly expanding the addressable market.
Phase 3 trial initiated in PSC, targeting a market with no approved therapies and data readout expected in 2031.
Diagnostic innovation and market opportunity in MASH
Non-invasive diagnostic technology (NIS2+) validated by leading consortia and included in major clinical guidelines.
NASHnext test reimbursed by Medicare as of August 2026, supporting broader adoption and future private insurer coverage.
U.S. laboratory market for NIS2+ projected to reach $1.5B peak annual revenue by 2033, driven by increased diagnosis and monitoring.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genfit
- Cash position strengthened by royalty financing, with Q1 revenue growth from IqirvoⓇ royalties.GNFT
Q1 2025 - NIS2+ enables scalable MASH diagnosis and monitoring, unlocking a $1.5B market opportunity.GNFTKOL event
- Robust pipeline and partnerships drive growth in rare liver diseases and diagnostics.GNFTCorporate presentation
- Q1 2026 revenue up 243% to €9.6M, with strong cash and major clinical milestones reached.GNFTQ1 2026 TU
- Expanding rare liver disease portfolio and diagnostics drive financial and clinical momentum.GNFTInvestor presentation
- Strong Iqirvo® sales and milestone revenue offset by one-time charges, with cash runway beyond 2028.GNFTQ4 2025
- Net loss of €10.0 million in H1 2025, cash runway extended beyond 2028 after VS-01 discontinuation.GNFTQ2 2025
- FDA approval and U.S. launch of Iqirvo® drove record profit, revenue, and strong cash outlook.GNFTQ2 2024
- GENFIT achieved profitability and secured major financing, fueling pipeline progress and commercial growth.GNFTQ4 2024
Next Genfit earnings date
Q2 202629 Sep, 2026
Genfit
Next Genfit earnings date
Q2 202629 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage